News Changes to the Lymphoma Canada Scientific Advisory Board We are happy to announce that Lymphoma Canada has selected new members of its Scientific…adminAugust 8, 2013
News IBM Canada’s Employee Charity Fund shines a light on Lymphoma Canada Jeff Penman, an executive with the Financial Services Group at IBM Canada Ltd, decided in…adminJuly 24, 2013
News Shedding Light on Lymphocytes The abnormal function of the CYMC gene is still an enigma waiting to be solved…adminJuly 22, 2013
Research Stanford University Study Shows Improvements in Overall Survival for Follicular Grade 1-2 Lymphoma Patients from 1960-2003 A study recently published by Dr. Daryl Tan and colleagues from Stanford University shows encouraging…adminJuly 10, 2013
Press Releases In the fight against cancer, do Quebeckers stand the same chance? A promising new drug for the treatment of indolent non-Hodgkin Lymphoma (iNHL) has not had…adminJuly 3, 2013
Press Releases Lymphoma Canada Report Card uncovers the need for education and support in the Canadian lymphoma community. MISSISSAUGA, June 27, 2013 – Today, Lymphoma Canada releases its 2013 Lymphoma Report Card, revealing…adminJune 27, 2013
News Lymphoma Report Card 2013 One in 30 Canadians in their lifetime will be diagnosed with lymphoma, yet a large…adminJune 27, 2013
Research Ontario funds rituximab for the treatment of relapsed Chronic Lymphocytic Leukemia (CLL) Lymphoma Canada applauds the Ontario government for its decision to expand the funding criteria for…adminJune 10, 2013
Research Canadian Provinces Fund New Treatment for patients with indolent non-Hodgkin’s Lymphoma (iNHL) and Mantle Cell Lymphoma (MCL) Lymphoma Canada applauds the recent reimbursement announcements by the provinces of Alberta, Saskatchewan and Ontario…adminMay 29, 2013
News Healthy mind, body, and soul It is said time and time again. Diet and exercise is important. Studies suggest that…adminMay 8, 2013